2022 Pharmacotherapy Preparatory Review and Recertification Course -- Pharmacokinetics: A Refresher, Nephrology, Oncology Supportive Care, and Gastrointestinal Disorders
Monday, April 25, 2022Available for 4.00 hours of CPE creditActivity Number: 0217-0000-22-015-H01-P Pharmacotherapy Preparatory Review and Recertification Course is ideal for pharmacy professionals preparing for the Board of Pharmacy Specialties (BPS) Pharmacotherapy Specialty Certification Examination, for Board Certified Pharmacotherapy Specialists (BCPSs) seeking recertification through continuing education, and for those seeking a self-paced review and refresher of pharmacotherapy topics.
Developed and presented by board-certified pharmacotherapy specialists, the course provides a comprehensive review of the knowledge domains covered in the pharmacotherapy specialty. Using a case-based approach, the course strongly emphasizes the thought processes needed to solve patient care problems in each therapeutic area.
Learning Objectives
- Identify and solve pharmacotherapy problems using basic pharmacokinetic concepts, including bioavailability, volume of distribution, clearance, and the elimination rate constant.
- Describe clinically relevant issues related to drug transport proteins, cytochrome P450 metabolism, pharmacogenomics, and drug sampling and interpretation.
- Describe specific pharmacokinetic characteristics and target concentrations of commonly used therapeutic agents, including aminoglycosides, vancomycin, phenytoin, valproic acid, and digoxin, as well as pharmacokinetic alterations in patients with renal and hepatic disease.
- Categorize acute kidney injury (AKI) and chronic kidney disease (CKD) on the basis of patient history, physical examination, laboratory values, and risk factors.
- Formulate therapeutic plans to slow progression of CKD or decrease the risk of AKI.
- Develop a care plan to manage common complications observed in patients with CKD (e.g.- anemia, hyperphosphatemia, secondary hyperparathyroidism).
- Interpret results of clinical trials related to the treatment of patients with kidney disease or complications.
- Identify, assess, and recommend appropriate pharmacotherapy for managing common complications of cancer chemotherapy, including nausea and vomiting, myelosuppression and the appropriate use of growth factors, infection, anemia and fatigue, cardiotoxicity, and extravasation injury.
- Assess and recommend appropriate pharmacotherapy for managing cancer-related pain.
- Assess and recommend appropriate pharmacotherapy for managing oncologic emergencies, including hypercalcemia, tumor lysis syndrome, and spinal cord compression.
- Review national guideline treatment strategies for the following gastrointestinal (GI) disorders: gastroesophageal reflux disease (GERD); peptic ulcer disease (PUD); ulcerative colitis (UC); Crohn disease (CD); chronic liver disease, including viral hepatitis and cirrhosis; constipation; diarrhea; irritable bowel syndrome (IBS); nausea; vomiting; pancreatitis; and upper GI bleeding, including prevention of stress-related mucosal disease (SRMD).
- Recommend appropriate pharmacologic and nonpharmacologic interventions given a specific patient with one or more GI disorders.
- Recognize pertinent information for educating patients and prescribers regarding the appropriate use of pharmacologic agents for various GI disorders.
- Evaluate and apply evidence related to GI disorders for patient care, including appropriate interpretation or use of study designs and statistical tests.
Pharmacokinetics: A Refresher
SpeakersSpeaker: Curtis L. Smith, Pharm.D., FCCP, BCPS Professor
Ferris State University, College of Pharmacy
Clinical Pharmacist
Sparrow Health System
Lansing, MichiganView Biography Smith |
Nephrology
SpeakersSpeaker: John M. Burke, Pharm.D., BCPS Professor, Pharmacy Practice
University of Health Sciences & Pharmacy in St. Louis
St. Louis, MissouriView Biography BurkeSpeaker: Andrew J. Crannage, Pharm.D., FCCP, BCPS Assistant Professor of Pharmacy Practice
St. Louis College of Pharmacy
St. Louis, Missouri
View Biography Crannage |
Oncology Supportive Care
SpeakersSpeaker: Christopher T. Elder, Pharm.D., BCOP Clinical Oncology Pharmacist
Florida Cancer Specialists and Research Institute
Adjunct Professor of Pharmacy Practice
Palm Beach Atlantic University
West Palm Beach, Florida
View Biography Elder |
Gastrointestinal Disorders
SpeakersSpeaker: Sheila M. Wilhelm, Pharm.D., FCCP, BCPS Clinical Professor and Coordinator of the Patient Care Laboratory
Wayne State University
Detroit, MI View Biography Wilhelm |